Perfluorochemical (PFC) liquid enhances recombinant adenovirus vector-mediated viral interleukin-10 (AdvIL-10) expression in rodent lung

Journal of Inflammation

Volumn 4, Issue , 2007, Pages

  Li, J T ^a,b   Bonneau, L A ^d   Zimmerman, J J ^b   Weiss, D J ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SEATTLE CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF VERMONT   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; INTERLEUKIN 10; PERFLUORO COMPOUND;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENDOTRACHEAL INTUBATION; HUMAN; HUMAN CELL; HYPOTHESIS; LOW DRUG DOSE; LUNG HOMOGENATE; LUNG LAVAGE; MALE; NONHUMAN; PNEUMONIA; PROTEIN EXPRESSION; RODENT;

ADENOVIRIDAE; MUS; RODENTIA;

EID: 34248586972     PISSN: None     EISSN: 14769255     Source Type: Journal    
DOI: 10.1186/1476-9255-4-9     Document Type: Article

References (35)

1. Adenoviral delivery of human and viral IL-10 in murine sepsis. RM Minter MA Ferry ME Murday CL Tannahill FR Bahjat C Oberholzer A Oberholzer D LaFace B Hutchins S Wen, J Immunol 2001 167 1053 1059 11441115
2. Adenovirus-mediated gene transfer of human interleukin 10 ameliorates reperfusion injury of rat lung isografts. H Itano W Zhang JH Ritter TJ McCarthy T Mohanakumar GA Patterson, J Thorac Cardiovasc Surg 2000 120 947 956 10.1067/mtc.2000.109240 11044321
3. Adenovirus-mediated gene transfer of viral interleukin-10 inhibits the immune response to both alloantigen and adenoviral antigen. L Qin Y Ding DR Pahud ND Robson A Shaked JS Bromberg, Hum Gene Ther 1997 8 1365 1374 9295131
4. Adenovirus-mediated interleukin-10 gene transfer inhibits post-transplant fibrous airway obliteration in an animal model of bronchiolitis obliterans. A Boehler D Chamberlain Z Xing AS Slutsky M Jordana J Gauldie M Liu S Keshavjee, Hum Gene Ther 1998 9 541 551 9525315
5. Airway-directed gene transfer of interleukin-10 using recombinant Sendai virus effectively prevents post-transplant fibrous airway obliteration in mice. F Shoji Y Yonemitsu S Okano I Yoshino K Nakagawa Y Nakashima M Hasegawa K Sugimachi K Sueishi, Gene Ther 2003 10 213 218 10.1038/sj.gt.3301847 12571628
6. Differential effects of IL-4 and IL-10 on IL-2-induced IFN-gamma synthesis and lymphokine-activated killer activity. DH Hsu KW Moore H Spits, Int Immunol 1992 4 563 569 10.1093/intimm/4.5.563 1627494
7. Effects of a perfluorochemical emulsion on the fate of circulating Pseudomonas aeruginosa. JD Brain RM Molina MM DeCamp AE Warner, Am J Physiol 1999 276 L1037 1045 10362729
8. Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. DH Hsu R de Waal Malefyt DF Fiorentino MN Dang P Vieira J de Vries H Spits TR Mosmann KW Moore, Science 1990 250 830 832 10.1126/science.2173142 2173142
9. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. KW Moore P Vieira DF Fiorentino ML Trounstine TA Khan TR Mosmann, Science 1990 248 1230 1234 10.1126/science.2161559 2161559
10. IL-10 inhibits cytokine production by activated macrophages. DF Fiorentino A Zlotnik TR Mosmann M Howard A O'Garra, J Immunol 1991 147 3815 3822 1940369
11. IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. P Ralph I Nakoinz A Sampson-Johannes S Fong D Lowe HY Min L Lin, J Immunol 1992 148 808 814 1730874
12. Impact of human interleukin-10 on vector-induced inflammation and early graft function in rat lung transplantation. M de Perrot S Fischer M Liu Y Imai S Martins S Sakiyama T Tabata XH Bai TK Waddell BL Davidson, Am J Respir Cell Mol Biol 2003 28 616 625 10.1165/rcmb.2002-0109OC 12707018
13. Inhibition of endotoxin-induced lung inflammation by interleukin-10 gene transfer in mice. S Dokka CJ Malanga X Shi F Chen V Castranova Y Rojanasakul, Am J Physiol Lung Cell Mol Physiol 2000 279 L872 877 11053022
14. Interleukin-10 gene therapy-mediated amelioration of bacterial pneumonia. DF Morrison DL Foss MP Murtaugh, Infect Immun 2000 68 4752 4758 10899882 10.1128/IAI.68.8.4752-4758.2000
15. Interleukin-10 inhibits interleukin-8 production in human neutrophils. P Wang P Wu JC Anthes MI Siegel RW Egan MM Billah, Blood 1994 83 2678 2683 8167346
16. Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action. JK Riley K Takeda S Akira RD Schreiber, J Biol Chem 1999 274 16513 16521 10.1074/jbc.274.23.16513 10347215
17. Lipid-mediated ex vivo gene transfer of viral interleukin 10 in rat lung allotransplantation. H Itano BN Mora W Zhang JH Ritter TJ McCarthy NS Yew T Mohanakumar GA Patterson, J Thorac Cardiovasc Surg 2001 122 29 38 10.1067/mtc.2001.114636 11436034
18. A liquid perfluorochemical decreases the in vitro production of reactive oxygen species by alveolar macrophages. TM Smith DM Steinhorn K Thusu BP Fuhrman P Dandona, Crit Care Med 1995 23 1533 1539 10.1097/00003246-199509000-00014 7664556
19. Liquid ventilation. DM Steinhorn AT Rotta, Acta Anaesthesiol Scand Suppl 1997 111 140 143 9420987
20. Liquid ventilation attenuates pulmonary oxidative damage. DM Steinhorn MC Papo AT Rotta A Aljada BP Fuhrman P Dandona, J Crit Care 1999 14 20 28 10.1016/S0883-9441(99)90004-7 10102720
21. Local delivery of the viral interleukin-10 gene suppresses tissue inflammation in murine Pneumocystis carinii infection. S Ruan C Tate JJ Lee T Ritter JK Kolls JE Shellito, Infect Immun 2002 70 6107 6113 12379687 10.1128/IAI.70.11.6107-6113.2002
22. Partial liquid ventilation decreases the inflammatory response in the alveolar environment of trauma patients. MA Croce TC Fabian JH Patton Jr SM Melton M Moore LL Trenthem, J Trauma 1998 45 273 280 discussion 280-272. 9715184
23. Partial liquid ventilation reduces pulmonary neutrophil accumulation in an experimental model of systemic endotoxemia and acute lung injury. AT Rotta DM Steinhorn, Crit Care Med 1998 26 1707 1715 10.1097/00003246-199810000-00026 9781729
24. The pathophysiology and treatment of sepsis. RS Hotchkiss IE Karl, N Engl J Med 2003 348 138 150 10.1056/NEJMra021333 12519925
25. Perflubron decreases inflammatory cytokine production by human alveolar macrophages. MJ Thomassen LT Buhrow HP Wiedemann, Crit Care Med 1997 25 2045 2047 10.1097/00003246-199712000-00023 9403756
26. Perfluorochemical liquid enhances adeno-associated virus-mediated transgene expression in lungs. DJ Weiss L Bonneau JM Allen AD Miller CL Halbert, Mol Ther 2000 2 624 630 10.1006/mthe.2000.0207 11124064
27. Perfluorochemical liquid-enhanced adenoviral vector distribution and expression in lungs of spontaneously breathing rodents. DJ Weiss TP Strandjord JC Jackson JG Clark D Liggitt, Exp Lung Res 1999 25 317 333 10.1080/ 019021499270222 10378103
28. Perfluorooctyl bromide (perflubron) attenuates oxidative injury to biological and nonbiological systems. AT Rotta B Gunnarsson BP Fuhrman B Wiryawan LJ Hernan DM Steinhorn, Pediatr Crit Care Med 2003 4 233 238 10.1097/01.PCC.0000059729.21375.D0 12749658
29. Prevention of lymphocyte cell death in sepsis improves survival in mice. RS Hotchkiss KW Tinsley PE Swanson KC Chang JP Cobb TG Buchman SJ Korsmeyer IE Karl, Proc Natl Acad Sci USA 1999 96 14541 14546 10588741 10.1073/pnas.96.25. 14541
30. Regulatory role of IL-10 in experimental obliterative bronchiolitis in rats. B Naidu B Krishnadasan RI Whyte RL Warner PA Ward MS Mulligan, Exp Mol Pathol 2002 73 164 170 10.1006/exmp.2002.2466 12565791
31. A single amino acid determines the immunostimulatory activity of interleukin 10. Y Ding L Qin SV Kotenko S Pestka JS Bromberg, J Exp Med 2000 191 213 224 10.1084/jem.191.2.213 10637267
32. Targeted adenovirus-induced expression of IL-10 decreases thymic apoptosis and improves survival in murine sepsis. C Oberholzer A Oberholzer FR Bahjat RM Minter CL Tannahill A Abouhamze D LaFace B Hutchins MJ Clare-Salzler LL Moldawer, Proc Natl Acad Sci USA 2001 98 11503 11508 11553765 10.1073/pnas.181338198
33. Transient increase in lung epithelial tight junction permeability: an additional mechanism for enhancement of lung transgene expression by perfluorochemical liquids. DJ Weiss T Beckett L Bonneau J Young JK Kolls G Wang, Mol Ther 2003 8 927 935 10.1016/j.ymthe.2003.09.003 14664795
34. Use of perflubron to enhance lung gene expression: safety and initial efficacy studies in non-human primates. DJ Weiss GB Baskin MK Shean JL Blanchard JK Kolls, Mol Ther 2002 5 8 15 10.1006/mthe.2001.0507 11786040
35. Viral interleukin-10-engineered autologous hematopoietic stem cell therapy: a novel gene therapy approach to prevent graft rejection. SK Salgar D Yang P Ruiz J Miller AG Tzakis, Hum Gene Ther 2004 15 131 144 10.1089/104303404772679940 14975186